Functional Neurosurgeon | Neuroprosthetics Researcher

Dr. Brandman in a gray suit and white shirt standing in a modern lobby with a blurred background of colorful bokeh lights.

David Brandman, M.D., Ph.D.

David Brandman, M.D., Ph.D., FRCSC is an Assistant Professor of Neurological Surgery at UC Davis. He is a fellowship-trained functional neurosurgeon who specializes in helping patients with movement disorders, epilepsy, chronic pain, and spasticity. He is an expert in the use of neuromodulation and minimally invasive approaches that minimize side-effects without compromising effectiveness.

Clinical Practice

Dr. Brandman is the primary adult epilepsy surgeon for California's largest sEEG surgical epilepsy program.

He provides comprehensive surgical care through The UC Davis Parkinson's Foundation Center of Excellence.

An expert in the use of neuromodulation and minimally invasive surgery, Dr. Brandman strives to make sure his patients feel heard and respected through their therapeutic journey.

Dr. David Brandman is performing neurosurgery in an operating room, with two monitors displaying medical images and various surgical equipment around them.

Research

Together with scientist Sergey Stavisky, Dr. Brandman co-directs the UC Davis Neuroprosthetics Lab. The goal of the group is to use fundamental insights of the human brain to develop next generation technologies helping people living with paralysis.

The capstone project of our group is the development of a speech neuroprosthesis designed to restore communication to people living with paralysis.

Dr. Sergey Stavisky and Dr. David Brandman stand in a modern hospital lobby with glass walls with colorful reflection in the background, smiling at the camera.

As Featured In

Clinical Trial

Logo with BrainGate clinical trial, with thin black and grey lettering and thin vertical lines in green and blue behind the "N".

Dr. Brandman is the UC Davis site-PI for the BrainGate2 clinical trial, focusing on developing a neural interface to restore communication and movement to people with paralysis.

Their work was awarded the 2024 Sean M. Healey International Prize for Innovation in ALS.

Dr. Brandman has been selected as the Study-PI for the upcoming early feasibility study from study sponsor Paradromics. The goal of this study is to characterize the safety of a novel neuroprosthesis focusing on restoring communication.

Paradromics logo, featuring simple lettering below an abstract graphic of a large black dot flanked by black brackets forming a square outline.